Sacrosidase
Orphan DrugFDA Approved
Description
Sucraid is a replacement enzyme therapy used to treat congenital sucrase-isomaltase deficiency (CSID). It replaces the missing or deficient sucrase enzyme, allowing patients to digest sucrose.
Indications & Therapeutic Use
Congenital sucrase-isomaltase deficiency (CSID)
Linked Diseases:
Global Availability (2 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Sacrosidase
| Generic Name | Sacrosidase |
| Brands | 1 brand available |
| Active Ingredient | Sacrosidase |
| Drug Class | Congenital sucrase-isomaltase deficiency (CSID) |
| Manufacturer | QOL Medical, LLC |
| Dosage Forms | Oral solution |
| Medical Code | A16AB07 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 2 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes